Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review

Open Access

1 January 2009

journal article
research article
Published by Springer Nature in Cardiovascular Diabetology

Vol. 8 (1) , 18
https://doi.org/10.1186/1475-2840-8-18

Abstract

Blood pressure lowering drugs are usually evaluated in short term trials determining the absolute blood pressure reduction during trough and the duration of the antihypertensive effect after single or multiple dosing. A lack of persistence with treatment has however been shown to be linked to a worse cardiovascular prognosis. This review explores the blood pressure reduction and persistence with treatment of antihypertensive drugs and the cost consequences of poor persistence with pharmaceutical interventions in arterial hypertension.

Keywords

This publication has 44 references indexed in Scilit:

Compliance with Antihypertensive Therapy in the Elderly
American Journal of Cardiovascular Drugs, 2008
Clinical practice and recent recommendations in hypertension management – reporting a gap in a global survey of 1259 primary care physicians in 17 countries
Current Medical Research and Opinion, 2007
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Hypertension, 2007
A meta-analysis of the association between adherence to drug therapy and mortality
BMJ, 2006
Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data
Hypertension, 2006
The Burden of Adult Hypertension in the United States 1999 to 2000
Hypertension, 2004
High prevalence and poor control of hypertension in primary care
Journal Of Hypertension, 2004
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
Hypertension, 2004
Pharmacoeconomics of Hypertension Management
PharmacoEconomics, 2001
Noncompliance with Antihypertensive Therapy
PharmacoEconomics, 1996